Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.82%
1,097.16
-9.20
-0.82%
1,106.361,105.681,109.291,097.26
SIXC
Communications
SIXC
Communications
SIXC
+0.45%
613.04
+2.75
+0.45%
610.29610.29614.07610.29
SIXE
Energy
SIXE
Energy
SIXE
+0.33%
1,215.19
+3.97
+0.33%
1,211.221,211.011,220.571,209.79
SIXI
Industrials
SIXI
Industrials
SIXI
-0.38%
1,743.78
-6.68
-0.38%
1,750.711,753.101,762.131,743.61
SIXM
Financials
SIXM
Financials
SIXM
+0.38%
630.57
+2.40
+0.38%
628.17629.38633.75629.38
SIXR
Staples
SIXR
Staples
SIXR
+0.22%
856.42
+1.85
+0.22%
854.57855.71859.22855.71
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.05%
216.77
-0.100
-0.05%
216.87216.87217.75216.17
SIXT
Technology
SIXT
Technology
SIXT
+1.10%
3,601.18
+39.24
+1.10%
3,561.943,571.443,605.343,562.15
SIXU
Utilities
SIXU
Utilities
SIXU
-0.01%
903.25
-0.060
-0.01%
903.31903.26906.56901.88
SIXV
Health care
SIXV
Health care
SIXV
-0.08%
1,480.30
-1.24
-0.08%
1,481.541,482.481,488.461,474.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.09%
2,402.15
+2.20
+0.09%
2,399.952,404.452,412.722,402.39
APLS:NASDAQ
Apellis Pharmaceuticals Inc
$41.03
0.00%
(0.00) 1D
May 13, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APLS...
Mkt. cap
5.25B
Avg. vol.
7.77M
Volume
0.00
P/E ratio
41.01
52-wk high
$41.14
52-wk low
$16.10
EPS
$1.00
Beta
-0.24
Shares outstanding
128.02M
No. of employees
736
News stories
From sources across the web
About Apellis Pharmaceuticals Inc
CEO-
Employees736
Founded2009
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Last report
May 7, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$0.15 / -$0.36
+141.35%beat
Revenue / Est. (USD)
268.30M / 203.05M
+32.14%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
178.49M
458.58M
199.91M
268.30M
Cost of goods sold
80.64M
92.72M
103.95M
117.50M
Cost of revenue
80.64M
92.72M
103.95M
117.50M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
131.14M
142.68M
147.10M
124.32M
Operating expense
131.14M
142.68M
147.10M
124.32M
Total operating expenses
211.78M
235.40M
251.06M
241.83M
Operating income
-33.29M
223.18M
-51.14M
26.47M
Other non operating income
146.00K
37.00K
-151.00K
88.00K
EBT including unusual items
-41.68M
216.32M
-58.64M
19.15M
EBT excluding unusual items
-41.68M
216.32M
-58.64M
19.15M
Income tax expense
466.00K
602.00K
313.00K
496.00K
Effective tax rate
-1.12%
0.28%
-0.53%
2.59%
Other operating expenses
-
-
-
-
Net income
-42.15M
215.72M
-58.95M
18.66M
Net profit margin
-23.61%
47.04%
-29.49%
6.95%
Earnings per share
-0.33
1.67
-0.47
0.15
Interest and investment income
2.61M
4.38M
3.50M
2.91M
Interest expense
-11.15M
-11.28M
-10.85M
-10.32M
Net interest expenses
-8.54M
-6.90M
-7.34M
-7.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
-32.84M
223.52M
-50.82M
26.76M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more